MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 4.310
+0.070 (1.65%)
Oct 8, 2026, 2:58 PM CST
MARX Biotech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,250 | 2,439 | 3,517 | - | - | - | |
Market Cap Growth | 3.40% | -30.65% | - | - | - | - |
Enterprise Value | 2,396 | 2,784 | 3,426 | - | - | - |
Last Close Price | 4.31 | 4.76 | 6.84 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 71.36 | 56.82 | - | - | - | - |
PS Ratio | 3.85 | 3.84 | 5.69 | - | - | - |
PB Ratio | 7.80 | 6.79 | 14.00 | - | - | - |
P/TBV Ratio | 10.10 | 8.38 | 22.03 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.10 | 4.38 | 5.54 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.76 | 0.85 | 1.10 | 0.01 | 0.23 | - |
Debt / EBITDA Ratio | - | - | - | - | 4.86 | - |
Debt / FCF Ratio | - | - | - | - | 1.29 | - |
Net Debt / Equity Ratio | 0.51 | 0.76 | 0.79 | -0.51 | -0.23 | -0.01 |
Net Debt / EBITDA Ratio | -1.03 | -2.12 | -2.80 | 10.61 | -12.17 | - |
Net Debt / FCF Ratio | -1.02 | -1.72 | -0.64 | 8.31 | -1.29 | -0.57 |
Asset Turnover | 0.83 | 0.81 | 1.10 | 1.16 | 1.89 | - |
Inventory Turnover | 1.67 | 1.69 | 1.57 | 1.84 | - | - |
Quick Ratio | 1.13 | 1.34 | 0.68 | 2.53 | 1.99 | 0.27 |
Current Ratio | 1.67 | 1.78 | 1.32 | 3.40 | 2.32 | 0.27 |
Return on Equity (ROE) | 12.45% | 13.82% | -35.58% | -7.30% | 7.66% | - |
Return on Assets (ROA) | -13.57% | -11.36% | -9.44% | -4.24% | 0.96% | - |
Return on Invested Capital (ROIC) | -22.62% | -19.19% | -28.69% | -17.88% | 1.73% | -6.42% |
Return on Capital Employed (ROCE) | -34.80% | -27.10% | -20.10% | -5.70% | 1.50% | -6.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.42% | 1.76% | -2.75% | - | - | - |
FCF Yield | -6.41% | -6.48% | -8.91% | - | - | - |
Dividend Yield | 1.33% | 1.21% | - | - | - | - |
Payout Ratio | - | - | - | - | 259.63% | - |
Buyback Yield / Dilution | -5.53% | -4.77% | -55.49% | 7.99% | -982.64% | - |
Total Shareholder Return | -4.20% | -3.56% | -55.49% | 7.99% | -982.64% | - |